Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - STOCK-BASED COMPENSATION
Stock-based Compensation ANVS - Annovis Bio, Inc.
4.63 M
LAST VALUE
-0.74%
2 YEAR CAGR
123.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR